NABL stock results show that N-able beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
Articles
FOLD Stock Earnings: Amicus Therapeutics Beats EPS, Misses Revenue for Q1 2024
FOLD stock results show that Amicus Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
Why Is CytomX (CTMX) Stock Down 43% Today?
CytomX Therapeutics stock is falling hard on Thursday after the company posted lackluster results in a cancer treatment clinical trial update. More
BRAG Stock Earnings: Bragg Gaming Group Misses EPS, Misses Revenue for Q1 2024
BRAG stock results show that Bragg Gaming Group missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
LNZA Stock Earnings: LanzaTech Global Misses EPS, Misses Revenue for Q1 2024
LNZA stock results show that LanzaTech Global missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q1 2024
MLYS stock results show that Mineralys Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. More
BHIL Stock Earnings: Benson Hill Misses EPS, Misses Revenue for Q1 2024
BHIL stock results show that Benson Hill missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
